Dr. Rugo on Chemotherapy for Metastatic Breast Cancer

BCNA Webcast- Global insights and local voices on metastatic breast cancerПодробнее

Dr Rugo on Managing Treatment-Limiting Toxicities in Breast CancerПодробнее

Addressing Current Questions and Controversies in the Management of Metastatic Breast CancerПодробнее

UCSF Bay Area Breast Cancer Forum: "Updates from ASCO 2024”Подробнее

Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate...Подробнее

DESTINY-Breast04 and Other Key Breast Cancer Studies at ASCO22Подробнее

Metastatic HER2-Positive and Triple-Negative BC | Annual National General Medical Oncology SummitПодробнее

Personalising treatment in ER+/Her2 negative Early Breast CancerПодробнее

ER-Positive Metastatic Breast Cancer | Third Annual National General Medical Oncology SummitПодробнее

UCSF Bay Area Breast Cancer Forum: "Updates in Radiation Therapy"Подробнее

ER-Positive Metastatic Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives ...Подробнее

Mastering the Art of Precision in the Treatment of HR+ Early and Metastatic Breast CancerПодробнее

The 2023 OncoAlert Colloquium (Breast Cancer)Подробнее

7 Dr Hope RugoПодробнее

Breast Cancer | Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-N...Подробнее

Picking the right CDK 4/6 inhibitor upfront for metastatic breast cancer.Подробнее

SABCS 2023 Breast Cancer Highlights – NATALEE, MONARCH-3, INAVO120, TROPION-Breast01Подробнее

Ribociclib in adjuvant HR+ breast cancerПодробнее

Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 StudyПодробнее

Breast Cancer | Hope S Rugo, MDПодробнее